| 1. | nlove21265 | |
| 2. | xuxaparkus | |
| 3. | eddenusa | |
| 4. | dancebunch | |
| 5. | snoruiz |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | xuxaparkus 06/03/2018 Immunomedics Reveals Promising Data for Sacituzumab Govitecan in Patients Heavily Pretreated for Metastatic Estrogen Receptor-Positive Breast Cancer |
| 2. | nlove21265 02/08/2018 Beats EPS loss estimates by $0.10. Misses on revenues. |
| 3. | eddenusa 04/25/2018 Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC) at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting |
| 4. | snoruiz 05/21/2018 Submits a BLA |
| 5. | xuxaparkus 05/17/2018 Reports 'positive' data for sacituzumab govitecan, its metastatic breast cancer drug |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Immunomedics, Inc.
- IMMU
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.